Japan approves world’s first Parkinson’s stem cell treatment to restore brain function
Japan’s Parkinson’s stem cell treatment has reached a landmark milestone after the country approved the world’s first iPSC-based therapy for the disease, offering real hope to an estimated 10 million patients globally. Developed by researchers at Kyoto University, the treatment transplants lab-grown dopamine-producing neurons directly into patients’ brains to replace those destroyed by Parkinson’s. Unlike existing medications that only manage symptoms, this approach attempts to restore the underlying neural machinery. Early trials showed measurable improvements in motor function, and Japan’s conditional approval now opens a genuine clinical pathway that simply did not exist before.









